Foundever ® and Cognigy Strengthen Strategic Partnership to Deliver Scalable Agentic AI Solutions Across the Globe
10.6.2025 14:00:00 CEST | Business Wire | Press Release
Foundever®, a global leader in the customer experience (CX) industry, today announced an expansion of its long-term collaboration with Cognigy, a global leader in AI-powered customer service solutions, in bringing Agentic AI into full-scale production across enterprise CX environments. This partnership addresses the increasing demand from global brands for sophisticated AI solutions that offer proactive, autonomous service, going beyond basic automation to deliver secure, scalable, personalized and human-centric interactions.
By integrating the large-scale and global operational capabilities of Foundever with Cognigy's powerful Agentic AI, this partnership redefines the possibilities of automation, exceeding the limitations of traditional chatbots. In a truly Agentic CX environment, Foundever ensures AI agents work seamlessly alongside humans to create a real, integrated experience across diverse customer journeys. With conversational design built on a depth of experience managing over 3.3 billion customer interactions each year, Foundever brings operational processes and training to empower both AI and human agents. Using data to drive continuous improvements across all aspects of the customer experience, the combined capabilities of Foundever and Cognigy connect data, technology and human expertise in ways that deliver unmatched value.
As organizations rush to incorporate AI, the truth is clear: simply showcasing impressive demos is not enough. Together, Foundever and Cognigy are bridging this gap while accelerating the transition of AI-powered CX into real-world applications, demonstrating tangible, measurable results. The proactive approach and strategic insight that Foundever brings into operationalizing AI technology highlights its role as both a beneficiary and a creator of substantial value. This partnership, already trusted by Fortune 500 brands worldwide, paves the way from innovative ideas to widespread enterprise implementation.
“At Foundever, we are dedicated to delivering solutions that provide real value at scale,” stated Laurent Uberti, President, CEO & Founder of Foundever. “Our collaboration with Cognigy is centered around deploying Agentic AI that operates effectively in production, at scale, and across various channels. Together, we’re establishing a new standard for what AI can achieve in customer interactions—enhancing CX while driving significant operational efficiencies. Our clients can expect not just advanced technology but also improved customer satisfaction, reduced operational costs and the ability to respond faster to market changes.”
As part of this partnership, Cognigy’s platform will integrate into the global CX operations of Foundever, enabling the deployment of multilingual, autonomous AI agents across both voice and digital channels. Built for adaptability, security and scalability, Cognigy empowers organizations to move beyond trial phases and embark on impactful, measurable transformations that yield substantial returns on investment. This expanded partnership is about delivering solutions that result in faster response times and improved customer engagement, ultimately driving growth for clients of Foundever and Cognigy.
“This expanded partnership with Foundever marks a pivotal step in bringing Agentic AI into real-world CX at scale,” said Philipp Heltewig, CEO and Co-founder at Cognigy. “We’ve already seen the value of combining Foundever’s global CX delivery with Cognigy’s AI Agent platform — and now we’re accelerating that impact. Together, we’re proving that AI Agents can do more than just automate — they can transform the way enterprises serve customers across channels, languages, and geographies.”
The partnership’s continued success was recognized at Nexus 2025, Cognigy’s flagship AI summit, where Foundever received the “Most Unique Use Case” award in the Innovation Champions category. With over 750 attendees from global brands, the event celebrated companies leveraging Cognigy’s AI Agents to deliver exceptional CX and tangible business impact.
With Foundever and Cognigy leading the charge, the future of AI-driven customer experience is here—powered by intelligent technology and a commitment to innovation. For more information on Foundever and its initiatives, visit foundever.com.
About Foundever
Foundever® is a global leader in the customer experience (CX) industry. With 150,000 associates across the globe, we’re the team behind the best experiences for +800 of the world’s leading and digital-first brands. Our innovative CX solutions, technology and expertise are designed to support operational needs for our clients and deliver a seamless experience to customers in the moments that matter.
Supporting +9 million customer conversations every day in +60 languages across 45 countries, Foundever combines global strength and scale with the agile, entrepreneurial approach of our founder-led culture, enabling companies of all sizes and industries to transform their CX. Sitel Group and SYKES are now Foundever.
Get to know us at www.foundever.com and connect with us on Facebook, LinkedIn and X.
About Cognigy
Cognigy is transforming the customer service industry with the most advanced AI Agent platform for enterprise contact centers. Its award-winning solution, Cognigy.AI, empowers enterprises to deliver instant, hyper-personalized, multilingual service on any channel. By integrating Generative and Conversational AI to create Agentic AI, Cognigy delivers AI Agents that redefine customer experiences, drive satisfaction, and support contact center employees in real-time. Over 1,000 brands worldwide trust Cognigy and its vast partner network to create AI customer service agents for their contact center. Cognigy's impressive worldwide customer portfolio includes Bosch, Nestlé, DHL, Frontier Airlines, Lufthansa Group, Mercedes-Benz and Toyota.
For more information and to book a demo visit: www.cognigy.com. Follow the company on X (formerly Twitter) @Cognigy and on LinkedIn at https://www.linkedin.com/company/cognigy.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610379651/en/
Contacts
Media contacts
Rebecca Sanders, Foundever
media@foundever.com
Cognigy
Cognigy@avenuez.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom